Inventor · disambiguated record
Ales Gavenda
Also filed as: GAVENDA ALES
5 granted patents·5 pending applications·24 citations·filing 2008–2016
73Inventor score
Top patents by PatentIndex Score
10 records- 0187US7759481B2Solid state forms of 5-azacytidine and processes for preparation thereofIVAX CORP·Filed 2008·Granted Jul 20, 2010·20 cites·20 claims
- 0277US9394266B2Solid state forms of cabazitaxel and processes for preparation thereofIVAX INT GMBH·Filed 2013·Granted Jul 19, 2016·2 cites·33 claims
- 0367US8618309B2Sunitinib and salts thereof and their polymorphsJEGOROV ALEXANDR·Filed 2009·Granted Dec 31, 2013·0 cites·5 claims
- 0465US10188648B2Solid state forms of selexipagTEVA PHARMACEUTICALS INT GMBH·Filed 2016·Granted Jan 29, 2019·2 cites·13 claims
- 0559US9067915B2Sunitinib and salts thereof and their polymorphsTEVA PHARMA·Filed 2013·Granted Jun 30, 2015·0 cites·5 claims
- 0654US2009131665A1Process for the preparation of crystalline forms A, B and pure crystalline form a of erlotinib HCIGAVENDA ALES·Filed 2008·Application pending·0 cites
- 0751US2010256392A1Polymorphs of sunitinib base and processes for preparation thereofTEVA PHARMA·Filed 2008·Application pending·0 cites
- 0848US2009124642A1Crystalline forms of Erlotinib HCI and formulations thereofCANAVESI AUGUSTO·Filed 2008·Application pending·0 cites
- 0944US2009012295A1Amorphous Erlotinib, processes for the preparation thereof, and processes to prepare additional forms of ErlotinibGAVENDA ALES·Filed 2008·Application pending·0 cites
- 1043US2010004449A1Crystalline forms of erlotinib base and erlotinib hclPLUS CHEMICALS SA·Filed 2009·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →